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Médecins Sans Frontières (MSF) has once again paved the way 
in local HIV/AIDS treatment, this time piloting ART adherence 
clubs in Khayelitsha outside Cape Town, improving adherence 
(and thus sustained virological suppression and immunological 
recovery)  over mainstream care by a full 12%.
Not only does the project, now involving 4 505 patients in some 
150 ‘clubs’ operating out of nine health facilities, reduce the patient 
load in mainstream care, enabling clinicians to better concentrate 
on new and relapsed patients, it also saves the health system and 
patients invaluable time and money. The collaboration between 
MSF, the Western Cape Department of Health and the Treatment 
Action Campaign (TAC) won a platinum award from the prestigious 
Impumelelo Social Innovations Centre and drew sustained applause 
when presented at the first-ever Southern African HIV Clinicians 
Society Conference in Cape Town late last year.
Setting up ART clubs within walking distance of the club members’ 
homes (most often in one of the member’s homes) is the end 
goal, but in the interim community facilities such as church and 
community halls and libraries are proving to be solid stepping stones 
and hugely effective. So far the clubs have reached 50% transition to 
full decentralisation and meet once every two months (the aim for 
optimal efficiency is to meet every three months).
A major boost for the club model has been the national health 
department shift to fixed-dose combinations (FDCs) in ART, 
considerably reducing the burden on clinic pharmacies to pre-pack 
or check pre-packs from the central dispensing service. MSF medical 
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co-ordinator for South Africa and Botswana, Dr Gilles von Cutsem, 
said that for South Africa’s 1.7 million people on ARVs, the FDC’s 
formulations in the 2012 - 2014 supply tender cut down the daily pill 
burden of 3 - 5 pills to just 1 pill, hugely enhancing the chances of 
life-long adherence. By simplifying the first-line adherence regimen 
not only were adherence clubs made more possible but prevention of 
mother-to-child HIV transmission (PMTCT) treatment options were 
expanded. FDC simplified the delivery of ART to pregnant women 
as soon as they tested positive, eliminating the need for infants to 
receive nevirapine syrup for the duration of breastfeeding because 
they were now protected through their mothers taking ARVs. Von 
Cutsem added that the changes (which include negotiating the 
world’s lowest price for ARVs by a country that consumes 21% of the 
world’s ARVs) made the ambitious target of getting 3 million people 
on ART by 2015 suddenly seem more achievable.
Success depends on upping staffing 
levels
Among several vital lessons learnt with the ART adherence clubs 
first piloted in Khayelitsha two years ago is that the cohort of patients 
divested into the club model remains the responsibility of the ART 
service. This requires sufficient human resources to support and run 
the clubs and cannot drain current facility staffing as the clubs expand. 
Says Van Cutsem, ‘where a facility rolls out more than a few clubs, 
club preparation and facilitation becomes a substantial role and using 
existing facility counsellors jeopardises their responsibilities towards 
ART preparation counselling, counselling non-adherent patients 
and tracing defaulters. Similarly, increasing your ART patients puts 
additional pressure on pharmacy staff. We recommend that additional 
club facilitator and pharmacy assistant posts be created and funded 
within the facility, NPO or primary healthcare team.’ The original pilot 
programme clearly demonstrated that club participation was associated 
with sustained virological suppression and immunological recovery 
and, after 40 months, 97% of club patients remained in care compared 
with 85% of those who qualified for clubs but remained in mainstream 
care. Club participants were 67% less likely to experience virological 
rebound. Von Cutsem said club eligibility centred on an ART patient 
being stable, clinically well and adhering to treatment. Clinicians used 
the following criteria: an adult patient of more than 40 kg no longer 
requiring dosage change according to weight change; on the same ART 
regimen for at least 12 months; their most recent consecutive viral 
loads  being undetectable; and having no medical condition requiring 
regular clinical consultations. Club sessions were structured to ensure 
that blood probes and annual clinical consultation and twice-yearly 
annual scripting were aligned for all club members, thus optimising 
efficiency and allowing the hub facility to plan when additional nurse 
support would be required. Club membership would be ended if the 
patient was found to have a viral load above 400, other safety blood 
results were ‘significantly abnormal’, developed TB, changed their ART 
regimen for clinical reasons or any other indications in the individual 
annual clinical follow-up. Membership could be resumed once the 
patient was adjudged clinically stable again.
A doctor’s perspective …
Dr Musaed Abrahams of the hugely stretched Ubuntu Clinic in 
Khayelitsha summed up initial clinician sentiment about the club 
system this way: ‘My day is spent seeing many patients who are 
otherwise well and stable on treatment. My time would be more 
Patients carefully check their single-dose ARV drug prescriptions under 
supervision at a Khayelitsha library adherence club meeting. Picture: 
Samantha Reinders.
The escalation of ART initiation over the last five 
years has shifted South Africa from a lingering 
global AIDS treatment pariah to universal 
admiration, but the country does not have the 
necessary capacity to double patient loads while 
managing an increasing number of patients at risk 
of failing their treatment. This is where the MSF 
intervention is proving to be worth its weight in 
gold.
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usefully spent focusing on starting new patients on ART and giving 
more time to my patients who are not doing well on their treatment. 
As the pressure on the health system increases, retention in care 
and adherence of patients on ART decrease.’ The national numbers 
dramatically illustrate his widely shared views: there were 1.79 
million patients initiated on ART by mid-2011 – with retention in 
care estimated at less than 60% at four years. South Africa’s National 
Strategic Plan for 2012 - 2016 targets 80% of all patients eligible 
on ART by 2016  (more than 3 million people), with 70% retained 
in care five years after treatment initiation. The escalation of ART 
initiation over the last five years has shifted South Africa from a 
lingering global AIDS treatment pariah to universal admiration, but 
the country does not have the necessary capacity to double patient 
loads while managing an increasing number of patients at risk of 
failing their treatment. This is where the MSF intervention is proving 
to be worth its weight in gold.
From a patient perspective the ART club model is a godsend, 
enabling job stability (taking a day off work every month to attend 
the clinic can create touchy employers), with quick access to  ART 
and clinical back-up as needed. 
The MSF’s Khayelitsha programme was the first in South Africa to 
provide ART at primary care level in the public sector, flying courageously 
in the face of government AIDS denialism, obfuscation and treacle-slow 
concessions during the controversial health ministry tenure of the late 
Dr Manto Tshabalala-Msimang. It is also one of two pilot projects in the 
country to provide decentralised care for drug-resistant tuberculosis.
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